// App-Quantinova.ai

P1389 : RUXOLITINIB DEMONSTRATES A GREATER CORTICOSTEROID-SPARING EFFECT THAN BEST AVAILABLE THERAPY IN PATIENTS WITH CORTICOSTEROID-REFRACTORY/DEPENDENT CHRONIC GRAFT-VS-HOST DISEASE

Researchers

Presenter

  • Robert Zeiser

Principal Investigators

  • Domenico Russo

  • Ron Ram

  • Shahrukh Hashmi

  • Ronjon Chakraverty

  • Jan Moritz Middeke

  • Sebestian Giebel

  • Maanasa Gowda

  • Sibel Gunes

  • Tommaso Stefanelli

  • Stephanie J. Lee

  • Takanori Teshima

  • Franco Locatelli

Medical Centers

  • Department of Medicine,Sheikh Shakhbout Medical City, Mayo Clinic,Abu Dhabi,Vereinigte Arabische Emirate

  • UCL Cancer Institute, Institute of Immunity and Transplantation,London,Royaume-uni

  • Novartis Farma SPA,Lombardy,Italien

  • Novartis Farma SPA,Lombardy,Italien

  • Department of Medicine I, Medical Center,University Freiburg,Freiburg,Deutschland

  • Tel Aviv Sourasky Medical Center and Sakler Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel

  • Department of Medicine,Sheikh Shakhbout Medical City, Mayo Clinic,Abu Dhabi,Vereinigte Arabische Emirate

  • Univer

  • Novartis Healthcare PVT. LTD,Hyderabad,印度

  • Novartis Pharmaceutical Corporation, East Hanover, NJ

  • Tel Aviv Sourasky Medical Center and Sakler Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel

  • University of Brescia, ASST-Spedali Civili Brescia,Brescia,Italië

  • Novartis Pharmaceuticals Corporation East Hanover NJ United States

  • Novartis Healthcare Pvt. Ltd, Hyderabad, India

  • De

  • Novartis Healthcare Pvt. Ltd, Hyderabad, India

  • Fred Hutchinson Cancer Research Center, Seattle, WA,Seattle, WA,Estados Unidos

  • Department of Hematology,Hokkaido University Faculty of Medicine,Sapporo,Japan

  • BMT Unit, Tel Aviv (Sourasky) Medical Center and Sackler Fac

  • Novartis Pharmaceuticals Corporation,East Hanover,Estados Unidos

  • Novartis Pharmaceuticals Corporation East Hanover NJ United States

  • University of Brescia, ASST-Spedali Civili Brescia,Brescia,Italië

  • Novartis Pharmaceuticals AG,Basel,Швейцария

  • Novartis Pharma Corp, Basel, Switzerland

  • Fred Hutchinson Cancer Research Center, Seattle, WA, United States

  • Novartis Farma SPA,Lombardy,Италия

  • Novartis Pharma AG,Basel,Svizzera

  • Department of Internal Medicine, Faculty of Medicine,University Medical Center Freiburg, University of Freiburg,Freiburg,Germania

  • Novartis Farma SPA,Lombardy,Italien

  • Department of Hematology,Hokkaido University Faculty of Medicine,Sapporo,Japan

  • Fred Hutchinson Cancer Research Center, Seattle, WA,Seattle, WA,Estados Unidos

  • Novartis Farma SPA,Lombardy,Italien

  • Novartis Pharma AG,Basel,Zwitserland

  • UCL Cancer institute and Institute of Immunity and Transplantation, London, United Kingdom

  • Universitätsklinikum "Carl Gustav Carus" der Technischen Universität Dresden, German Cancer Consortium (DKTK), German Cancer Research Center (DKFZ), and National Center for Tumor Diseases (NCT) Dresden,Dresden,Allemagne

  • Novartis Pharmaceuticals Corporation,East Hanover,Verenigde Staten

  • Novartis Pharmaceutical Corporation, East Hanover, NJ

  • UCL Cancer institute and Institute of Immunity and Transplantation, London, United Kingdom

  • UCL Cancer Institute, Institute of Immunity and Transp

  • University of Brescia and Spedali Civili di Brescia, Brescia, Italy

  • The Department of Bone Marrow Transplantation and Onco-Hematology,Maria Sklodowska-Curie National Research Institute of Oncology,Gliwice,Pologne

  • Dipartimento di Oncoematolo

  • Department of Hematology,Hokkaido University Faculty of Medicine,Sapporo,Japan

  • University of Brescia, ASST-Spedali Civili Brescia,Brescia,Italië

  • Department of Medicine,Sheikh Shakhbout Medical City, Mayo Clinic,Abu Dhabi,Vereinigte Arabische Emirate

  • University of Brescia, ASST-Spedali Civili Brescia,Brescia,Italië

  • Fred Hutchinson Cancer Research...

  • Fred Hutchinson Cancer Research Center, Seattle, WA, United States

  • Fred Hutchinson Cancer Research Center, Seattle, WA, United States

  • Department of Medicine,Sheikh Shakhbout Medical City, Mayo Clinic,Abu Dhabi,Vereinigte Arabische Emirate

  • Department of Internal Medicine, Faculty of Medicine,University Medical Center Freiburg, University of Freiburg,Freiburg,Germania

  • UCL Cancer Institute, Institute of Immunity and Transplantation,London,Vereinigtes Königreich

  • Novartis Pha

  • Universitätsklinikum "Carl Gustav Carus" der Technischen Universität Dresden, German Cancer Consortium (DKTK), German Cancer Research Center (DKFZ), and National Center for Tumor Diseases (NCT) Dresden,Dresden,Allemagne

  • Novartis Healthcare Pvt. Ltd.,Hyderabad,Индия

  • Novartis Farma SPA,Lombardy,Italien

  • Depart

  • Novartis Healthcare Pvt. Ltd, Hyderabad, India

  • Novartis Healthcare PVT. LTD,Hyderabad,印度

  • Novartis Pharma AG,Basel,Svizzera

  • The Department of Bone Marrow Transplantation and Onco-Hematology,Maria Sklodowska-Curie National Research Institute of Oncology,Gliwice,Pologne

  • Department of Medicine I, Faculty of Medicine, Medical Center,University of Freiburg,Freiburg,Germany

  • Fred Hutchinson Cancer Research Center, Seattle, WA,Seattle, WA,Estados Unidos

  • Tel Aviv Sourasky Medical Center and Sakler Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel

  • Novartis Pharma AG,Basel,Svizzera

  • Department of Bone Marrow Transplantation & Oncohematology, Maria Sklodowska-Curie Institute of Oncology, Gliwice, Poland

  • Novartis Pharma AG,Basel,Svizzera

  • Novartis Farma SPA,Lombardy,Italien

  • Novartis Healthcare PVT. LTD,Hyderabad,印度

  • Novartis Pharma AG,Basel,Svizzera

  • Department of Hematology,Hokkaido University Faculty of Medicine,Sapporo,Japan

Locations

  • Germany

  • Italy

  • Israel

  • United Arab Emirates

  • United Kingdom

  • Poland

  • Pakistan

  • India

  • United States

  • Switzerland

  • Japan

Companies

  • N/A

Study Components

Therapeutic Area

  • N/A

Disease

  • N/A

Biomarkers

  • N/A

Drug/Treatment

  • Ruxolitinib phosphate

  • Prednisone

Outcome

  • N/A

Study Design

  • Randomized

Phase

  • III

Study Id's

  • NCT03112603

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved